Conditions: survodutide · 5 mg/mL.
I have done this once and I suspect I got away with it rather than got it right.
For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.
What does a defensible version of this look like in practice?
Nobody has published a cycle count, and at 5 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.5 mg and every microlitre is 5 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 5 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 5 mg/mL and the date, and never thaw a container you will refreeze.
The part that matters: buffer components crystallise at different rates during freezing, which shifts pH locally by a surprising amount.
Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.
The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.
Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.
Aliquoting itself is a handling step and introduces its own contamination opportunity.
Let a frozen vial reach room temperature before opening, or you condense water into it.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsAnswer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.
A dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.
The relevant detail is that during freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.
The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.
Aliquot before the first freeze. That is the whole answer.
edited 7 Mar 2026 by RP_C18 — reworded for clarity after a comment
The relevant physics is ice-front concentration: as water crystallises, everything dissolved is concentrated into the shrinking liquid phase, including buffer salts.
Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.
Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.
Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.
Dry powder tolerates cycles far better than solution does.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.